Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis

This study has been completed.

Study NCT00318994 Information provided by AstraZeneca

First Received: April 26, 2006 Last Updated: January 11, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2007
Primary Completion Date:	September 2005 (Final data collection date for primary outcome measure)